Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa

Peer Review reports

Original Submission
4 Nov 2023	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
5 Dec 2023	Reviewed	Reviewer Report - Susanna S van Wyk
7 Dec 2023	Reviewed	Reviewer Report
15 Dec 2023	Author responded	Author comments - Katherine Charlene McNabb
Resubmission - Version 3
15 Dec 2023	Submitted	Manuscript version 3
24 Jan 2024	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
30 Jan 2024	Editorially accepted
23 Feb 2024	Article published	10.1186/s12889-024-17924-0

Back to article page